Insider Transactions in Q1 2022 at Healthstream Inc (HSTM)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2022
|
Frank Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+1.34%
|
-
|
Mar 17
2022
|
Thompson Dent Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.06%
|
-
|
Mar 17
2022
|
Linda Rebrovick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+5.34%
|
-
|
Mar 17
2022
|
Michael D Shmerling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.08%
|
-
|
Mar 17
2022
|
William Stead Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+6.98%
|
-
|
Mar 17
2022
|
Tate Deborah Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+10.65%
|
-
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,291
-0.03%
|
$24,529
$19.94 P/Share
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,298
+0.11%
|
-
|
Mar 17
2022
|
Trisha L Coady Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-6.42%
|
$18,487
$19.94 P/Share
|
Mar 17
2022
|
Trisha L Coady Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,072
+21.18%
|
-
|
Mar 17
2022
|
Michael Manning Collier Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,241
-5.11%
|
$23,579
$19.94 P/Share
|
Mar 17
2022
|
Michael Manning Collier Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,186
+17.6%
|
-
|
Mar 17
2022
|
Jeff Cunningham Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,113
-7.67%
|
$21,147
$19.94 P/Share
|
Mar 17
2022
|
Jeff Cunningham Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,663
+24.32%
|
-
|
Mar 17
2022
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-15.4%
|
$20,501
$19.94 P/Share
|
Mar 17
2022
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,048
+30.31%
|
-
|
Mar 17
2022
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-9.12%
|
$14,079
$19.94 P/Share
|
Mar 17
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,058
+27.34%
|
-
|
Mar 17
2022
|
Kevin P O'Hara Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-11.23%
|
$3,496
$19.94 P/Share
|
Mar 17
2022
|
Kevin P O'Hara Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
782
+32.3%
|
-
|
Mar 17
2022
|
J Edward Pearson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,421
-1.79%
|
$64,999
$19.94 P/Share
|
Mar 17
2022
|
J Edward Pearson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,048
+6.83%
|
-
|
Mar 17
2022
|
Scott Alexander Roberts CFO and SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-6.44%
|
$12,578
$19.94 P/Share
|
Mar 17
2022
|
Scott Alexander Roberts CFO and SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+20.76%
|
-
|
Mar 17
2022
|
Michael Sousa Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,083
-11.73%
|
$115,577
$19.94 P/Share
|
Mar 17
2022
|
Michael Sousa Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
21,048
+28.87%
|
-
|
Mar 17
2022
|
Jeffrey L Mclaren Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+12.9%
|
-
|
Mar 10
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
466
+0.38%
|
$9,320
$20.12 P/Share
|
Mar 10
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+0.62%
|
$5,600
$20.12 P/Share
|
Mar 10
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.15%
|
$5,960
$20.12 P/Share
|
Mar 08
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
200
-1.0%
|
-
|
Mar 07
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
400
-1.96%
|
-
|
Feb 24
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Open market or private purchase
|
Direct |
500
+8.98%
|
$9,500
$19.12 P/Share
|
Jan 31
2022
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-3.11%
|
$3,048
$24.45 P/Share
|
Jan 31
2022
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
356
+8.01%
|
-
|
Jan 31
2022
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
579
-11.25%
|
$13,896
$24.45 P/Share
|
Jan 31
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+27.47%
|
-
|
Jan 08
2022
|
Kevin P O'Hara Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-29.7%
|
$9,050
$25.62 P/Share
|
Jan 08
2022
|
Kevin P O'Hara Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,219
+50.0%
|
-
|